400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-10-12
高血压靶向治疗药物研发商
医药研发/制造
Omega Funds;
Omega Funds;
泛大西洋投资;
泛大西洋投资;
Perceptive Advisors;
RTW Investments;
Sofinnova Partners;
Sixty Degree Capital;
VenBio Partners;
Adage Capital Management;
CinRx;
5AM Ventures;
Rock Springs Capital;
BVF Partners
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10